e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Physiology of human pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The indirect Fick method is an unfeasible method for hemodynamic assessment in pulmonary arterial hypertension patients
S. Desole, S. Czekay, T. Bollmann, K. Lau, R. Ewert, C. M. Kaehler (Innsbruck, Austria; Greifswald, Germany)
Source:
Annual Congress 2011 - Physiology of human pulmonary hypertension
Session:
Physiology of human pulmonary hypertension
Session type:
Thematic Poster Session
Number:
2310
Disease area:
Pulmonary vascular diseases
Abstract
The indirect Fick method (Fick
Ind
) is often used for the hemodynamic evaluation in pulmonary arterial hypertension (PAH). As the Fick
Ind
calculates the cardiac output (CO) assuming physiological VO
2
values, this method might be unfeasible for patients with pulmonary vascular diseases. We evaluated the suitability of hemodynamic data obtained by Fick
Ind
in PAH.
Right heart catheterization was performed in 43 PAH patients (age 61±13 yrs) and 9 controls. 61% of patients suffered from idiopathic PAH, 30% from PAH associated with connective tissue diseases, the remaining 9% from other forms of PAH. Hemodynamic results obtained by Fick
Ind
were compared to data from the thermodilution (TD) method.
Patients and controls did not differ in age and BSA. No significant difference between heart rates during the different techniques was detected in either group. Mean CO determined by Fick
Ind
(CO
Fick
) was 4.3±1.8 and 4.7±1.2 L/min in PAH patients and controls, respectively. In PAH patients CO by TD method (CO
Thermo
) was consistently higher than CO
Fick
(4.9±2.0 L/min) showing a significant difference (Wilcoxon; p<0.001). In controls CO
Thermo
was 5.4±1.4 L/min (not significant to CO
Fick
). Agreement analysis of CO
Thermo
with CO
Fick
revealed a comparable bias between methods in both groups (0.5±1.1 L/min in patients; 0.65±0.82 L/min in controls) with wider limits of agreement for the patient cohort (-1.6 to 2.6 L/min versus -1.0 to 2.3 L/min in controls).
Determination of CO by the Fick
Ind
cannot be used in PAH patients as this method consequently underestimates CO. It can be suggested that the estimated VO
2
values in use for the calculation of the CO are invalid for PAH patients.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Desole, S. Czekay, T. Bollmann, K. Lau, R. Ewert, C. M. Kaehler (Innsbruck, Austria; Greifswald, Germany). The indirect Fick method is an unfeasible method for hemodynamic assessment in pulmonary arterial hypertension patients. Eur Respir J 2011; 38: Suppl. 55, 2310
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Thermodilution and Fick cardiac output measurement comparison in patients with pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
A simple non-invasive diagnostic algorithm for pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension
Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020
Year: 2020
A noninvasive algorithm to exclude pre-capillary pulmonary hypertension
Source: Eur Respir J 2011; 37: 1096-1103
Year: 2011
The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Non-invasive hemodynamic assessment in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Non-invasive estimation of cardiac output by impedance cardiography during incremental exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2011 - Innovative methods in exercise testing
Year: 2011
Value of MR-phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 424s
Year: 2006
Cardiac output measurement by thermodilution using right heart catheter versus noninvasive rebreathing technique in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Noninvasive cardiac output measurements in patients with pulmonary hypertension
Source: Eur Respir J 2013; 42: 125-133
Year: 2013
Is cardiac output assessed by inert gas rebreathing technique predictive of mortality in pulmonary hypertension?
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Non-invasive measurement of stroke volume using an inert gas rebreathing device in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
The impact of pulmonary parameters on non-invasive measurement of cardiac output by the inert gas rebreathing method
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Reproducibility of non-invasive measures of arterial stiffness in mild to severe stable COPD using a new cuff-based operator independent device
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
The assessment of heart chambers volumes using modified transpulmonary thermodilution in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Non-invasive methods for assessing pulmonary exercise haemodynamics
Source: International Congress 2016 – PG17 Pulmonary haemodynamics during exercise
Year: 2016
Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Cardiac bioimpedance as a non-invasive tool in patients with pulmonary hypertension
Source: Annual Congress 2011 - Innovative methods in exercise testing
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept